GLP-1 receptor agonists are a class of medications that mimic the action of glucagon-like peptide-1, a hormone that enhances insulin secretion, suppresses glucagon release, and slows gastric emptying, thereby aiding in blood glucose control. They are significant in managing type 2 diabetes and obesity, as they promote weight loss and improve glycaemic control. An example is liraglutide, which can also lead to gastrointestinal side effects such as nausea.
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.